Verified Nov 2026
Other
·

Schaffhausen, Canton of Schaffhausen
·
Since 1959
Ewopharma AG, founded in 1959 and headquartered in Schaffhausen, Switzerland, is a pharmaceutical marketing and commercialization organization serving 15 countries across Central Eastern Europe and Switzerland. With 200-500 employees and estimated revenue of $100-250 million, the privately held company bridges pharmaceutical innovators with patients through market access strategies, regulatory support, and product launches. The company distributes proprietary brands including Revalid® and Isoprinosine® alongside partner products across prescription, OTC, and consumer health segments.
Ewopharma at a glance
Revenue
$100-250M
Est. band
Employees
200-500
Founded
1959
Headquarters
Schaffhausen, Canton of Schaffhausen
Industries
Automotive
Electric Vehicles
Medical
Overview
Ewopharma AG, founded in 1959 and headquartered in Schaffhausen, Switzerland, is a pharmaceutical marketing and commercialization organization serving 15 countries across Central Eastern Europe and Switzerland. With 200-500 employees and estimated revenue of $100-250 million, the privately held company bridges pharmaceutical innovators with patients through market access strategies, regulatory support, and product launches. The company distributes proprietary brands including Revalid® and Isoprinosine® alongside partner products across prescription, OTC, and consumer health segments.
At a glance
Attribute | Detail |
|---|---|
Founded | 1959 |
Headquarters | Schaffhausen, Canton of Schaffhausen |
Employees | 200-500 |
Revenue | $100-250M (estimated) |
What Ewopharma makes
The company provides market access strategies, regulatory affairs support, pharmacovigilance services, and comprehensive commercialization services spanning autoimmune, respiratory, gastroenterology, and oncology segments.
Latest developments
2026-10-12 — ewopharma:Ewopharma and Purpose Pharma Announce a Strategic Partnership for the Commercialization of Attrogy in Selected Central and Eastern European Countries (ewopharma.ee)
2026-10-12 — ewopharma: Press Releases (ewopharma.com)
2026-07-07 — ewopharma:Ewopharma and Protina – Strengthening the Presence of Diasporal and Basica in Bulgaria with a new partnership (ewopharma.com)
2026-05-29 — ewopharma:Ewopharma and Dr. Falk Pharma renew their long-standing partnership - a commitment built to last (ewopharma.com)
2026-02-26 — ewopharma:BioGaia AB extends long-standing distribution partnership with Ewopharma (ewopharma.com)
Company details
Ewopharma operates as a private company with approximately 447 staff, including over 350 professionals dedicated to market access, commercialization, and regulatory functions. Ewopharma was founded in 1959, has an estimated 200-500 employees, and is headquartered in Schaffhausen, Canton of Schaffhausen.
Frequently asked questions
What does Ewopharma do?
Ewopharma AG, founded in 1959 and headquartered in Schaffhausen, Switzerland, is a pharmaceutical marketing and commercialization organization serving 15 countries across Central Eastern Europe and Switzerland. With 200-500 employees and estimated revenue of $100-250 million, the privately held company bridges pharmaceutical innovators with patients through market access strategies, regulatory support, and product launches. The company distributes proprietary brands including Revalid® and Isoprinosine® alongside partner products across prescription, OTC, and consumer health segments.
Where is Ewopharma headquartered?
Ewopharma is headquartered in Schaffhausen, Canton of Schaffhausen.
When was Ewopharma founded?
Ewopharma was founded in 1959.
How big is Ewopharma?
Ewopharma has an estimated 200-500 employees, with revenue in the $100-250M range (estimated).
Related suppliers
Explore other suppliers in the LightSource directory:
Last verified Nov 2026. Is this your company? Request a correction.
Location & contact
Evaluating suppliers like these?
This profile is part of a public-data sample of the full LightSource directory. Book a demo to see the full LightSource marketplace and supplier discovery platform — 1M+ credible suppliers, with AI-run sourcing events.
